The ROE as of November 2025 (TTM) for Immune Therapeutics, Inc. (IMUN) is 110.65%

According to Immune Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 110.65%. This represents a change of 3.86% compared to the average of 2.79% of the last 4 quarters.

Immune Therapeutics, Inc. (IMUN) Historical ROE (quarterly & annually)

How has IMUN ROE performed in the past?

The mean historical ROE of Immune Therapeutics, Inc. over the last ten years is -235.09%. The current 110.65% ROE has changed -147.07% with respect to the historical average. Over the past ten years (40 quarters), IMUN's ROE was at its highest in in the September 2022 quarter at 175.04%. The ROE was at its lowest in in the December 2014 quarter at -733.07%.

Immune Therapeutics, Inc. (IMUN) ROE by Quarter and Year

Discovering the peaks and valleys of Immune Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immune Therapeutics, Inc. (IMUN) Average ROE

How has IMUN ROE performed in the past?

The current ROE of Immune Therapeutics, Inc. (IMUN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Immune Therapeutics, Inc. (IMUN) ROE vs. Peers

How is IMUN’s ROE compared to its peers?

Immune Therapeutics, Inc.’s ROE is greater than Tetra Bio-Pharma Inc. (-467.81%), greater than Forward Pharma A/S (-2.53%), greater than Polydex Pharmaceuticals Limited (-53.04%), greater than Bionomics Limited (-7.94%), less than MDxHealth S.A. (716.68%), less than Tryp Therapeutics Inc. (402.50%), greater than HealthBeacon plc (-56.54%), greater than Top Strike Resources Corp. (-72.68%), less than Intellipharmaceutics International Inc. (27.35%), less than Carebook Technologies Inc. (6.88%),

Build a custom stock screener for Immune Therapeutics, Inc. (IMUN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immune Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immune Therapeutics, Inc. (IMUN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immune Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.